Article
Trends In Dealmaking
As the page turned on 2025, optimism was high among life sciences dealmakers. Elections in the U.S. and other major economies had concluded, interest rates were poised to come in to focus, and the regulatory environment appeared to favor increased activity.

Ballard Spahr LLP